{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:23:51Z","timestamp":1759335831054},"reference-count":37,"publisher":"Oxford University Press (OUP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1093\/jac\/dku471","type":"journal-article","created":{"date-parts":[[2014,12,5]],"date-time":"2014-12-05T23:45:50Z","timestamp":1417823150000},"page":"914-921","source":"Crossref","is-referenced-by-count":8,"title":["Impact of ertapenem on antimicrobial resistance in a sentinel group of Gram-negative bacilli: a 6 year antimicrobial resistance surveillance study"],"prefix":"10.1093","volume":"70","author":[{"given":"Carlos A.","family":"Rodriguez-Osorio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cesar O.","family":"Sanchez-Martinez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Araujo-Melendez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elia","family":"Criollo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandro E.","family":"Macias-Hernandez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfredo","family":"Ponce-de-Leon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio","family":"Ponce-de-Leon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose","family":"Sifuentes-Osornio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2014,12,4]]},"reference":[{"key":"key\n\t\t\t\t20170511115853_DKU471C1","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1086\/506438","article-title":"Potential confounding in evaluating infection-control interventions in hospital settings: changing antibiotic prescription","volume":"43","author":"Nijssen","year":"2006","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170511115853_DKU471C2","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1086\/521255","article-title":"Statistical analysis and application of quasi experiments to antimicrobial resistance intervention studies","volume":"45","author":"Shardell","year":"2007","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170511115853_DKU471C3","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ijantimicag.2011.08.018","article-title":"Carbapenem stewardship: does ertapenem affect Pseudomonas susceptibility to other carbapenems? A review of the evidence","volume":"39","author":"Nicolau","year":"2012","journal-title":"Int J Antimicrob Agents"},{"key":"key\n\t\t\t\t20170511115853_DKU471C4","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.1128\/AAC.00472-10","article-title":"Antimicrobial stewardship lessons: do Pseudomonas-sparing agents, such as ertapenem, effectively improve bacterial resistance?","volume":"54","author":"dos Santos","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170511115853_DKU471C5","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.diagmicrobio.2012.09.018","article-title":"Impact of susceptibility profiles of Gram-negative bacteria before and after the introduction of ertapenem at a medical center in northern Taiwan from 2004 to 2010","volume":"75","author":"Lee","year":"2013","journal-title":"Diagn Microbiol Infect Dis"},{"key":"key\n\t\t\t\t20170511115853_DKU471C6","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1093\/jac\/dki009","article-title":"Selectivity of ertapenem for Pseudomonas aeruginosa mutants cross-resistant to other carbapenems","volume":"55","author":"Livermore","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20170511115853_DKU471C7","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.molmed.2012.03.003","article-title":"Carbapenem resistance in Enterobacteriaceae: here is the storm?","volume":"18","author":"Nordmann","year":"2012","journal-title":"Trends Mol Med"},{"key":"key\n\t\t\t\t20170511115853_DKU471C8","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/S1473-3099(07)70082-8","article-title":"The ORION statement: guidelines for transparent reporting of outbreak reports and intervention studies of nosocomial infection","volume":"7","author":"Stone","year":"2007","journal-title":"Lancet Infect Dis"},{"key":"key\n\t\t\t\t20170511115853_DKU471C9","first-page":"71","article-title":"Tools to investigate the use of medicines","volume-title":"Drug and Therapeutics Committees: A Practical Guide","author":"Holloway","year":"2003"},{"key":"key\n\t\t\t\t20170511115853_DKU471C10","volume-title":"ATC\/DDD Index","author":"WHO Collaborating Centre for Drug Statistics Methodology"},{"key":"key\n\t\t\t\t20170511115853_DKU471C11","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1086\/591861","article-title":"NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006\u20132007","volume":"29","author":"Hidron","year":"2008","journal-title":"Infect Control Hosp Epidemiol"},{"key":"key\n\t\t\t\t20170511115853_DKU471C12","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1093\/jac\/dkr141","article-title":"Change in antipseudomonal carbapenem susceptibility in 25 hospitals across 9 years is not associated with the use of ertapenem","volume":"66","author":"Eagye","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20170511115853_DKU471C13","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.diagmicrobio.2011.03.009","article-title":"The effects of group 1 versus group 2 carbapenems on imipenem-resistant Pseudomonas aeruginosa: an ecological study","volume":"70","author":"Carmeli","year":"2011","journal-title":"Diagn Microbiol Infect Dis"},{"key":"key\n\t\t\t\t20170511115853_DKU471C14","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1017\/S0950268811000082","article-title":"Changes in antibiotic usage and susceptibility in nosocomial Enterobacteriaceae and Pseudomonas isolates following the introduction of ertapenem to hospital formulary","volume":"140","author":"Graber","year":"2012","journal-title":"Epidemiol Infect"},{"key":"key\n\t\t\t\t20170511115853_DKU471C15","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1093\/jac\/dks385","article-title":"Association of ertapenem and antipseudomonal carbapenem usage and carbapenem resistance in Pseudomonas aeruginosa among 12 hospitals in Queensland, Australia","volume":"68","author":"McDougall","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20170511115853_DKU471C16","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1093\/jac\/dkt091","article-title":"Impact of ertapenem use on Pseudomonas aeruginosa and Acinetobacter baumannii imipenem susceptibility rates: collateral damage or positive effect on hospital ecology?","volume":"68","author":"Sousa","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20170511115853_DKU471C17","doi-asserted-by":"crossref","first-page":"3217","DOI":"10.1128\/AAC.49.8.3217-3221.2005","article-title":"Acquisition of resistant bowel flora during a double-blind randomized clinical trial of ertapenem versus piperacillin-tazobactam therapy for intraabdominal infections","volume":"49","author":"DiNubile","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170511115853_DKU471C18","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s10096-005-1356-0","article-title":"Bowel colonization with resistant gram-negative bacilli after antimicrobial therapy of intra-abdominal infections: observations from two randomized comparative clinical trials of ertapenem therapy","volume":"24","author":"DiNubile","year":"2005","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"key\n\t\t\t\t20170511115853_DKU471C19","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jinf.2008.06.001","article-title":"Ertapenem: no effect on aerobic gram-negative susceptibilities to imipenem","volume":"57","author":"Goff","year":"2008","journal-title":"J Infect"},{"key":"key\n\t\t\t\t20170511115853_DKU471C20","doi-asserted-by":"crossref","first-page":"5597","DOI":"10.1128\/AAC.00742-11","article-title":"Reduction in fluoroquinolone use following introduction of ertapenem into a hospital formulary is associated with improvement in susceptibility of Pseudomonas aeruginosa to group 2 carbapenems: a 10-year study","volume":"55","author":"Cook","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170511115853_DKU471C21","first-page":"1","article-title":"Carbapenem stewardship: positive impact on hospital ecology","volume":"15","author":"Lima","year":"2011","journal-title":"Braz J Infect Dis"},{"key":"key\n\t\t\t\t20170511115853_DKU471C22","doi-asserted-by":"crossref","first-page":"5122","DOI":"10.1128\/AAC.00064-09","article-title":"Introduction of ertapenem into a hospital formulary: effect on antimicrobial usage and improved in vitro susceptibility of Pseudomonas aeruginosa","volume":"53","author":"Goldstein","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl","key":"key\n\t\t\t\t20170511115853_DKU471C23","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1016\/S0924-8579(12)70006-7","article-title":"Correlation between carbapenem consumption and resistance to carbapenems among Enterobacteriaceae isolates collected from patients with intra-abdominal infections at five medical centers in Taiwan, 2006\u20132010","volume":"40","author":"Ho","year":"2012","journal-title":"Int J Antimicrob Agents"},{"key":"key\n\t\t\t\t20170511115853_DKU471C24","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.ijantimicag.2012.10.014","article-title":"Monitoring the global in vitro activity of ertapenem against Escherichia coli from intra-abdominal infections: SMART 2002\u20132010","volume":"41","author":"Hawser","year":"2013","journal-title":"Int J Antimicrob Agents"},{"key":"key\n\t\t\t\t20170511115853_DKU471C25","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.diagmicrobio.2012.04.007","article-title":"Antimicrobial resistance among Gram-negative bacilli isolated from Latin America: results from SENTRY Antimicrobial Surveillance Program (Latin America, 2008\u20132010)","volume":"73","author":"Gales","year":"2012","journal-title":"Diagn Microbiol Infect Dis"},{"key":"key\n\t\t\t\t20170511115853_DKU471C26","first-page":"34","article-title":"Increasing prevalence of extended-spectrum-\u03b2-lactamase among Gram-negative bacilli in Latin America\u20142008 update from the Study for Monitoring Antimicrobial Resistance Trends (SMART)","volume":"15","author":"Villegas","year":"2011","journal-title":"Braz J Infect Dis"},{"key":"key\n\t\t\t\t20170511115853_DKU471C27","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.diagmicrobio.2013.02.031","article-title":"Trends in susceptibility of selected gram-negative bacilli isolated from intra-abdominal infections in North America: SMART 2005\u20132010","volume":"76","author":"Babinchak","year":"2013","journal-title":"Diagn Microbiol Infect Dis"},{"key":"key\n\t\t\t\t20170511115853_DKU471C28","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1099\/jmm.0.059816-0","article-title":"A 10 year surveillance for antimicrobial susceptibility of Escherichia coli and Klebsiella pneumoniae in community- and hospital-associated intra-abdominal infections in China","volume":"62","author":"Yang","year":"2013","journal-title":"J Med Microbiol"},{"key":"key\n\t\t\t\t20170511115853_DKU471C29","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/1471-2334-9-61","article-title":"Ten years of antibiotic consumption in ambulatory care: trends in prescribing practice and antibiotic resistance in Austria","volume":"9","author":"Metz-Gercek","year":"2009","journal-title":"BMC Infect Dis"},{"key":"key\n\t\t\t\t20170511115853_DKU471C30","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1086\/660100","article-title":"Hand hygiene, and not ertapenem use, contributed to reduction of carbapenem-resistant Pseudomonas aeruginosa rates","volume":"32","author":"Pires dos Santos","year":"2011","journal-title":"Infect Control Hosp Epidemiol"},{"key":"key\n\t\t\t\t20170511115853_DKU471C31","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1086\/510393","article-title":"Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship","volume":"44","author":"Dellit","year":"2007","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170511115853_DKU471C32","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1016\/B978-0-443-06839-3.00222-8","article-title":"Acinetobacter species","volume-title":"Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases","author":"Allen","year":"2010"},{"issue":"Suppl 4","key":"key\n\t\t\t\t20170511115853_DKU471C33","doi-asserted-by":"crossref","first-page":"S341","DOI":"10.1086\/382690","article-title":"\u201cCollateral damage\u201d from cephalosporin or quinolone antibiotic therapy","volume":"38","author":"Paterson","year":"2004","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170511115853_DKU471C34","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1038\/nrmicro1047","article-title":"Epidemiological interpretation of antibiotic resistance studies\u2014what are we missing?","volume":"2","author":"Schwaber","year":"2004","journal-title":"Nat Rev Microbiol"},{"key":"key\n\t\t\t\t20170511115853_DKU471C35","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1093\/infdis\/jis933","article-title":"Abrupt emergence of a single dominant multidrug-resistant strain of Escherichia coli","volume":"207","author":"Johnson","year":"2013","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20170511115853_DKU471C36","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1128\/JCM.00045-11","article-title":"First characterization of CTX-M-15-producing Escherichia coli ST131 and ST405 clones causing community-onset infections in South America","volume":"49","author":"Ruiz","year":"2011","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20170511115853_DKU471C37","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.diagmicrobio.2013.03.026","article-title":"Molecular epidemiology of Escherichia coli O25b-ST131 isolates causing community-acquired UTIs in Mexico","volume":"76","author":"Reyna-Flores","year":"2013","journal-title":"Diagn Microbiol Infect Dis"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/70\/3\/914\/16864272\/dku471.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,23]],"date-time":"2017-08-23T10:19:13Z","timestamp":1503483553000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article-lookup\/doi\/10.1093\/jac\/dku471"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,4]]},"references-count":37,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2014,12,4]]},"published-print":{"date-parts":[[2015,3]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dku471","relation":{},"ISSN":["1460-2091","0305-7453"],"issn-type":[{"value":"1460-2091","type":"electronic"},{"value":"0305-7453","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12,4]]}}}